Mishpacha-Article-February-2011.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Passover and Firstfruits Chronology
PASSOVER AND FIRSTFRUITS CHRONOLOGY Three Views Dating the Events From Yeshua’s Last Passover to Pentecost by Michael Rudolph Bikkurim: Plan or Coincidence? In the covenant given through Moses, God commanded the Israelites that when they came into the land God had given them, they were to sacrifice a sheaf of their bikkurim1 – their first fruits of the harvest – as a wave offering: “And the Lord spoke to Moses, saying, ‘Speak to the children of Israel, and say to them: ‘When you come into the land which I give to you, and reap its harvest, then you shall bring a sheaf of its firstfruits of your harvest to the priest.’” (Leviticus 23:9-10) This was to be done on “the day after the Sabbath,” and was to be accompanied by a burnt offering of an unblemished male lamb: “He shall wave the sheaf before the Lord, to be accepted on your behalf; on the day after the Sabbath the priest shall wave it. And you shall offer on that day, when you wave the sheaf, a male lamb of the first year, without blemish, as a burnt offering to the Lord.” (Leviticus 23:11-12) Then, in the New Covenant Scriptures, we read: “But now Messiah is risen from the dead, and has become the firstfruits of those who have fallen asleep. For since by man came death, by man also came the resurrection of the dead. For as in Adam all die, even so in Messiah all shall be made alive. But each one in his own order: Messiah the firstfruits, afterward those who are Messiah’s at His coming.” (1 Corinthians 15:20-23) Are the references to “firstfruits” in both the New and Old Covenants coincidental, or are they God’s intricate plan for relating events across the span of centuries? In the sections which follow, this paper demonstrates that they are no coincidence, and that understanding the offering of firstfruits is prophetically important in the dating the events from Yeshua’s last Passover to the arrival of the Holy Spirit. -
CARRIER SCREENING: POPULATION DIFFERENCES, STIGMA, and the SPECTER of Co-Authored with EUGENICS Stephen Pemberton Tay Sachs KEITH WAILOO, PH.D
CARRIER SCREENING: POPULATION DIFFERENCES, STIGMA, AND THE SPECTER OF Co-authored with EUGENICS Stephen Pemberton Tay Sachs KEITH WAILOO, PH.D. Disease Martin Luther King Jr. Professor Cystic Fibrosis RUTGERS UNIVERSITY Sickle Cell Disease DEPARTMENT OF HISTORY INSTITUTE FOR HEALTH, HEALTH CARE POLICY, AND AGING RESEARCH RESEARCH SUPPORTED BY: ETHICAL, LEGAL, AND SOCIAL ISSUES (ELSI) PROGRAM, NHGRI; and THE JAMES S. MCDONNELL FOUNDATION Lessons of the Past: • Balancing the screening interests of individuals, communities, and society? The importance of historical sensitivity and cultural competence among health practitioners who engage in screening • How to target screening to distinct populations? The challenge of “hidden” versus obvious subpopulations. One-size does not fit all; how screening relates to group values and concerns • In health care, knowing when screening is not the answer for some populations. Other goals: treatment and extension of life, relief. The importance of competent screening programs among populations whose group identities are invested in the maintenance of values that are distinctively different than that of the majority culture. TODAY: ONE HISTORICAL CASE STUDY (TAY-SACHS DISEASE), WITH SICKLE CELL DISEASE AND CYSTIC FIBROSIS AS BACKDROP CONTROVERSIES in CARRIER SCREENING, STIGMATIZATION, AND POPULATION – the case of sickle cell disease • LINUS PAULING 1968: “I have suggested that there should be tatooed on the forehead of every young person a symbol showing possession of the sickle cell gene or whatever other -
Introduction to the Text
Copyright © 2015, Princeton University Press. No part of this book may be distributed, posted, or reproduced in any form by digital or mechanical means without prior written permission of the publisher. Introduction to the Text Wendy Laura Belcher This volume introduces and translates the earliest known book-length biography about the life of an African woman: the Gädlä Wälättä ̣eṭrosP . It was written in 1672 in an African language by Africans for Africans about Africans—in particular, about a revered African religious leader who led a successful nonviolent movement against European protocolonialism in Ethiopia. This is the first time this remark- able text has appeared in English. When the Jesuits tried to convert the Ḥabäša peoples of highland Ethiopia from their ancient form of Christianity to Roman Catholicism,1 the seventeenth- century Ḥabäša woman Walatta Petros was among those who fought to retain African Christian beliefs, for which she was elevated to sainthood in the Ethiopian Ortho- dox Täwaḥədo Church. Thirty years after her death, her Ḥabäša disciples (many of whom were women) wrote a vivid and lively book in Gəˁəz (a classical African language) praising her as an adored daughter, the loving friend of women, a de- voted reader, an itinerant preacher, and a radical leader. Walatta Petros must be considered one of the earliest activists against European protocolonialism and the subject of one of the earliest African biographies. The original text is in a distinctive genre called agädl , which is used to tell the inspirational story of a saint’s life, often called a hagiography or hagiobiography (de Porcellet and Garay 2001, 19). -
Tay Sachs Disease Testing
Autosomal recessive mutations Genetic diseases & testing The story of three genetic diseases Phenylketonuria Reading: Chapter 12; and pp 201-202 Sickle-Cell Anemia Tay-Sachs Disease Phenylketonuria (PKU), Sickle-Cell Anemia and Tay-Sachs Disease are autosomal Frequencies of Sickle-Cell Anemia and Tay- recessive diseases. Sachs Disease alleles in different populations. carrier Disease is expressed in Sickle-Cell Anemia matings between carriers 10-40% of the population in regions of equatorial (heterozygotes). Africa are carriers <1% of South Africans are carriers Most affected individuals have unaffected parents. Tay-Sachs Increased frequency with 1/25 American Ashkenazi Jews are carriers inbreeding. 1/300 in the general population are carriers Why are the frequencies of some Hemoglobin disease alleles so high? Major protein in red blood cells. Hemoglobin is made of four Explanation #1 polypeptide chains--2 alpha and Heterozygote advantage 2 beta chains--and four heme- iron complexes. These complexes bind O2. Explanation #2 Founder effect Hemoglobin releases CO2 and binds O2 when CO2 concentrations are low. i.e., in the lungs. Hb binds CO2 and releases O2 when CO2 concentrations high. A single amino acid change in the beta peptide results in sickle cell anemia Why is the carrier frequency so high? Carriers have an advantage in malaria-infested areas Genotype disease malaria HbA/HbA normal susceptible HbA/HbS normal resistant Tay Sachs The Founder Effect Progressive disease with an onset in infancy of developmental retardation, followed by paralysis, dementia and blindness. Death occurs in the second or third year of life. Tay-Sachs disease is caused by mutation in the hexosaminidase A gene, which removes fatty substances called gangliosides. -
The WWARN Malaria Data Inventory
The WWARN Malaria Data Inventory - Data Dictionary This is freely available to use as a reference guide for understanding the data variables listed in data files stored in the WWARN Malaria Data Inventory. This file is subject to change, to access the latest version of this file, please visit the WWARN website page here: https://www.wwarn.org/accessing-data. To ask questions relating to the dictionary, please email: [email protected] Please note these important considerations when reviewing the WWARN Data Dictionary: Not every study contributed to WWARN collected all the variables listed in the Data Dictionary In a publication, Data Contributors may have reported collecting data listed in the Data Dictionary, but may not have shared those variables with WWARN Occasionally some studies contain data listed in the Data Dictionary that will require curation before release. The vast majority of data is already fully curated and this only happens for very old data sets or data that may have been shared incrementally. We will let you know after receiving your request if the data requires curation and the time this is expected to take. Variable's Range - Range - Table Name Variable Name Variable Definition Variable's Controlled Terminology Default Unit HIGH value LOW value SUBJECT TABLE This is the WWARN-generated study identifier - it will be the same for all subjects within a Subject sid unique data contribution. Subject site This is the name of the study site for the subject. This is the contributor-provided subject identifier used within the study. This is not unique in the repository as some studies could use the same naming conventions. -
View the PDF Document
RABBI NORMAN LAMM SEPTEMBER 19, 1970 THE JEWISH CENTER SHABBAT KI TAVO THE FRUITS OF UNITY As one year draws to a close and a new one is about to begin, I bring you greetings from the Holy Land — the land about which it is written (Deut. 11:12) Tl/i) )<- do \ ^ >>l £k 7> mm a land which the Lord thy God cares about; constantly are the eyes of the Lord thy God upon it, from the beginning of the year to the end of the year. It is a beautiful, exciting, lovely, inspiring -- and holy land, even in times of crisis* I tell this to you not to convey in- formation which you did not know before, but rather as a way of mu- tually affirming love and affection for this land of ours. The temper of Israelis has undergone a rather serious change as a result of recent events. Most of them are upset, angry, and dis- appointed in the United States Government. It is true that governments can change their minds, especially on the basis of their own national interest. Sometimes they can even be fickle. But the shocking action of the American Government towards Israel is simply inexcusable. The guarantees that America gave Israel concerning the cease-fire were mere- ly the first of a long list of guarantees in a yet-secret letter that Pres. Nixon sent to Mrs. Meir. When the United States failed to honor those initial commitments, and when, in addition, the State and Defense Departments ridiculed Israel, Israel refused to go any further in what -2- seemed to be an international farce. -
The Contemporary Jewish Legal Treatment of Depressive Disorders in Conflict with Halakha
t HaRofei LeShvurei Leiv: The Contemporary Jewish Legal Treatment of Depressive Disorders in Conflict with Halakha Senior Honors Thesis Presented to The Faculty of the School of Arts and Sciences Brandeis University Undergraduate Program in Near Eastern and Judaic Studies Prof. Reuven Kimelman, Advisor Prof. Zvi Zohar, Advisor In partial fulfillment of the requirements for the degree of Bachelor of Arts by Ezra Cohen December 2018 Accepted with Highest Honors Copyright by Ezra Cohen Committee Members Name: Prof. Reuven Kimelman Signature: ______________________ Name: Prof. Lynn Kaye Signature: ______________________ Name: Prof. Zvi Zohar Signature: ______________________ Table of Contents A Brief Word & Acknowledgments……………………………………………………………... iii Chapter I: Setting the Stage………………………………………………………………………. 1 a. Why This Thesis is Important Right Now………………………………………... 1 b. Defining Key Terms……………………………………………………………… 4 i. Defining Depression……………………………………………………… 5 ii. Defining Halakha…………………………………………………………. 9 c. A Short History of Depression in Halakhic Literature …………………………. 12 Chapter II: The Contemporary Legal Treatment of Depressive Disorders in Conflict with Halakha…………………………………………………………………………………………. 19 d. Depression & Music Therapy…………………………………………………… 19 e. Depression & Shabbat/Holidays………………………………………………… 28 f. Depression & Abortion…………………………………………………………. 38 g. Depression & Contraception……………………………………………………. 47 h. Depression & Romantic Relationships…………………………………………. 56 i. Depression & Prayer……………………………………………………………. 70 j. Depression & -
Carrier Screening Panels for Ashkenazi Jews: Is More Better? Jennifer R
March 2005 ⅐ Vol. 7 ⅐ No. 3 article Carrier screening panels for Ashkenazi Jews: Is more better? Jennifer R. Leib, MS1,2, Sarah E. Gollust, BA3,4, Sara Chandros Hull, PhD3,4, and Benjamin S. Wilfond, MD3,4 Purpose: To describe the characteristics of Ashkenazi Jewish carrier testing panels offered by US Laboratories, including what diseases are included, the labels used to describe the panels, and the prices of individual tests compared to the prices of panels for each laboratory. Methods: GeneTests (http://www.genetests.org) was searched for laboratories that offered Tay-Sachs disease testing. Information was obtained from laboratory web sites, printed brochures, and telephone calls about tests/panels. Results: Twenty-seven laboratories offered up to 10 tests. The tests included two diseases associated with death in childhood (Niemann-Pick type A and Tay-Sachs disease), five with moderate disability and a variably shortened life span (Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia, and mucolipidosis type IV), and two diseases that are not necessarily disabling or routinely shorten the lifespan (Gaucher disease type I and DFNB1 sensorineural hearing loss). Twenty laboratories offered a total of 27 panels of tests for three to nine diseases, ranging in price from $200 to $2082. Of these, 15 panels cost less than tests ordered individually. The panels were described by 24 different labels; eight included the phrase Ashkenazi Jewish Disease or disorder and six included the phrase Ashkenazi Jewish Carrier. Conclusion: There is considerable variability in the diseases, prices, and labels of panels. Policy guidance for establishing appropriate criteria for inclusion in panels may be useful to the Ashkenazi Jewish community, clinicians, and payers. -
Tanya Sources.Pdf
The Way to the Tree of Life Jewish practice entails fulfilling many laws. Our diet is limited, our days to work are defined, and every aspect of life has governing directives. Is observance of all the laws easy? Is a perfectly righteous life close to our heart and near to our limbs? A righteous life seems to be an impossible goal! However, in the Torah, our great teacher Moshe, Moses, declared that perfect fulfillment of all religious law is very near and easy for each of us. Every word of the Torah rings true in every generation. Lesson one explores how the Tanya resolved these questions. It will shine a light on the infinite strength that is latent in each Jewish soul. When that unending holy desire emerges, observance becomes easy. Lesson One: The Infinite Strength of the Jewish Soul The title page of the Tanya states: A Collection of Teachings ספר PART ONE לקוטי אמרים חלק ראשון Titled הנקרא בשם The Book of the Beinonim ספר של בינונים Compiled from sacred books and Heavenly מלוקט מפי ספרים ומפי סופרים קדושי עליון נ״ע teachers, whose souls are in paradise; based מיוסד על פסוק כי קרוב אליך הדבר מאד בפיך ובלבבך לעשותו upon the verse, “For this matter is very near to לבאר היטב איך הוא קרוב מאד בדרך ארוכה וקצרה ”;you, it is in your mouth and heart to fulfill it בעזה״י and explaining clearly how, in both a long and short way, it is exceedingly near, with the aid of the Holy One, blessed be He. "1 of "393 The Way to the Tree of Life From the outset of his work therefore Rav Shneur Zalman made plain that the Tanya is a guide for those he called “beinonim.” Beinonim, derived from the Hebrew bein, which means “between,” are individuals who are in the middle, neither paragons of virtue, tzadikim, nor sinners, rishoim. -
Re'eh / Labor Day / Rosh Hodesh Elul 5779
Todah to Today’s Torah Readers: Aden Jeral, Pam Sommers, Dinah Leventhal, Susan Kimmel, and (both interpreting & chanting the Haftarah) Philip Abrams! And daveners Beth Sperber Richie, Larry Goldsmith, Cheryl Hurwitz, & Ben Cohen! Torah: Rishon – Deuteronomy 15:1-6 (page 1440 / 1269 new) Sheni – Deut.15:7-11 Shlishi – Deut.15:12-18 Maftir – Numbers 28:9-15 (page 1210 / 1082 new) Haftarah - Isaiah 54:11-55:5 (page 1604 / 1290 new) Re’eh / Labor Day / Rosh Hodesh Elul 5779 Mazel Tov to Jackie Gran and Aaron Strauss as they welcome new baby Oriana! Mazel Tov to Marie Vanderbilt and Mike Robinson (son of Gerald and Sara) on their Aufruf! Rabbi Jill Jacobs on Deut. 15 (Jewish Lights, 2009) There Shall be No Needy: Pursuing Social Justice through Jewish Law and Tradition In the book of Deuteronomy, Moses prepares the Jewish people for his imminent death by recounting the exodus narrative and by reminding the people of some essential divine laws.… Moses’ final instructions…may be read as an exhortation not to be corrupted by newfound power and wealth, but rather to use this new position to establish a just society. “There shall be no needy among you—for Adonai will surely bless you in the land which Adonai your God gives you for an inheritance to possess it if you diligently listen to the voice of Adonai your God, and observe and do the commandment that I command you this day. If there is among you a needy person, one of your brethren, within any of your gates, in your land which Adonai your God gives you, you shall not harden your heart, nor shut your hand from your needy brother; but you shall surely open your hand unto him[/her/them]”. -
Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series
International Journal of Molecular Sciences Review Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series 1, 2, 3, , Aleksandra Jezela-Stanek y , El˙zbietaCiara y and Karolina M. Stepien * y 1 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 2 Department of Medical Genetics, The Children’s Memorial Heath Institute, 04-730 Warsaw, Poland; [email protected] 3 Adult Inherited Metabolic Diseases, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK * Correspondence: [email protected] These authors contributed equally to this work. y Received: 31 May 2020; Accepted: 23 June 2020; Published: 26 June 2020 Abstract: Mucolipidosis type IV (MLIV) is an ultra-rare lysosomal storage disorder caused by biallelic mutations in MCOLN1 gene encoding the transient receptor potential channel mucolipin-1. So far, 35 pathogenic or likely pathogenic MLIV-related variants have been described. Clinical manifestations include severe intellectual disability, speech deficit, progressive visual impairment leading to blindness, and myopathy. The severity of the condition may vary, including less severe psychomotor delay and/or ocular findings. As no striking recognizable facial dysmorphism, skeletal anomalies, organomegaly, or lysosomal enzyme abnormalities in serum are common features of MLIV, the clinical diagnosis may be significantly improved because of characteristic ophthalmological anomalies. This review aims to outline the pathophysiology and genetic defects of this condition with a focus on the genotype–phenotype correlation amongst cases published in the literature. The authors will present their own clinical observations and long-term outcomes in adult MLIV cases. -
Judaism, Genetic Screening and Genetic Therapy Part 2
Jerusalem Science Contest החידון המדע הירושלמי Judaism, Genetic Screening and Genetic Therapy Part 2 The Jerusalem Science contest lecture on Judaism, Genetic Screening and Genetic Therapy – Part 2 1 Judaism, Genetic Screening and Genetic Therapy FRED ROSNER, M.D., F.A.C.P. OCTOBER/NOVEMBER 1998 NUMBER 5 & 6 VOLUME 65:406-413 From the Director, Department of Medicine, Mount Sinai Services at Queens Hospital Center, Jamaica, NY, and Professor of Medicine, Mount Sinai School of Medicine, New York, NY. Address correspondence to Fred Rosner, M.D., F.A.C.P., Queens Hospital Center, 82-68 164th Street, Jamaica, NY 11432 or address e-mail to: [email protected] Presented at the 8th annual International Conference on Jewish Medical Ethics. San Francisco, CA, February 15, 1997. Fred Rosner, M.D., F.A.C.P., Professor of Medicine at Mount Sinai School of Medicine, currently serves as the Director, Department of Medicine, Queens Hospital Center in New York City. Dr. Rosner, an internationally known authority on medical ethics, is the founding and former Chairman of the Medical Ethics Committee of the Medical Society of the State of New York and is the former Co-Chairman of the Medical Ethics Committee of the Federation of Jewish Philanthropies of New York. Dr. Rosner, a prolific writer, is the author of widely acclaimed books and articles on Jewish medical ethics and Jewish medical history. He also serves as a reviewer and editor for many medical journals. In part 2, we continue to review a presentation and essay by Dr. Fred Rosner delivered on February 15, 1997 at the 8th annual Conference on Jewish Medical Ethics, San Francisco, California.